Robertson Stephens Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Sell
2,962
-26
-0.9% -$3.9K 0.01% 454
2026
Q1
$456K Buy
+2,988
New +$458K 0.01% 434
2025
Q2
Sell
-3,134
Closed -$349K 580
2025
Q1
$349K Sell
3,134
-392
-11% -$41.7K 0.01% 425
2024
Q4
$343K Buy
3,526
+210
+6% +$22.4K 0.01% 436
2024
Q3
$381K Sell
3,316
-140
-4% -$15.9K 0.01% 476
2024
Q2
$368K Buy
3,456
+47
+1% +$4.72K 0.02% 381
2024
Q1
$342K Sell
3,409
-170
-5% -$17.4K 0.02% 404
2023
Q4
$361K Hold
3,579
0.02% 352
2023
Q3
$365K Hold
3,579
0.02% 355
2023
Q2
$361K Hold
3,579
0.03% 327
2023
Q1
$329K Sell
3,579
-130
-4% -$11.4K 0.03% 350
2022
Q4
$336K Hold
3,709
0.03% 315
2022
Q3
$281K Sell
3,709
-173
-4% -$14.3K 0.03% 288
2022
Q2
$328K Sell
3,882
-305
-7% -$26.8K 0.03% 286
2022
Q1
$367K Sell
4,187
-251
-6% -$21.7K 0.03% 283
2021
Q4
$388K Sell
4,438
-115
-3% -$9.55K 0.03% 291
2021
Q3
$372K Sell
4,553
-222
-5% -$20K 0.04% 230
2021
Q2
$435K Buy
4,775
+239
+5% +$21.3K 0.05% 220
2021
Q1
$387K Buy
+4,536
New +$407K 0.06% 203

Other funds holding NVS

Robertson Stephens Wealth Management's NVS Position: Q2 2026 in Review

Robertson Stephens Wealth Management reduced its Novartis (NVS) stake by 0.87% in Q2 2026, selling an estimated $3.9K and leaving 2,962 shares worth $464K. The position accounts for 0.01% of the portfolio, ranked #454.

Robertson Stephens Wealth Management first reported a position in NVS in Q1 2021 and has held it in 19 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Robertson Stephens Wealth Management held 2,962 shares of Novartis worth $464K as of Q2 2026.
  • Robertson Stephens Wealth Management sold 26 Novartis shares in Q2 2026, an estimated $3.9K.
  • Novartis made up 0.01% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #454 holding.
  • Robertson Stephens Wealth Management first reported a position in Novartis in Q1 2021 and has held it in 19 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.